The reason for this discrepancy is unknown, but an atheroprotective role of antigen presentation via MHCII is supported by the finding that TLR-activated CD11c+ DCs promote Treg development and function in association with increased atherosclerosis [290]. This evidence concerns the gene ITGAX and atherosclerosis.